Who owns Regulus Therapeutics? - WallStreetZen

Who owns Regulus Therapeutics? Regulus Therapeutics ( NASDAQ : RGLS ) is owned by 86.61% institutional shareholders, 272.23% Regulus Therapeutics insiders, and 0.00% retail investors. Ravi Viswanathan is the largest individual Regulus Therapeutics shareholder, …

61%
OFF

Who Owns Regulus Therapeutics? - WallStreetZen

1 week from now

wallstreetzen.com

$525.60
OFF

Regulus Therapeutics Inc Stock - WallStreetZen

1 week from now

3 days ago · Regulus Therapeutics. stock was originally listed at a price of $525.60 in Oct 9, 2012. If you had invested in Regulus Therapeutics stock at $525.60, your return over the last …

wallstreetzen.com

64%
OFF

With 64% Institutional Ownership, Regulus Therapeutics Inc.

1 week from now

Dec 8, 2024 · A look at the shareholders of Regulus Therapeutics Inc. (NASDAQ:RGLS) can tell us which group is most powerful.We can see that institutions own the lion's share in the …

yahoo.com

$100
OFF

Regulus Therapeutics Announces Oversubscribed $100 Million …

1 week from now

SAN DIEGO, March 12, 2024 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative …

regulusrx.com

85%
OFF

Neuphoria Therapeutics Stock Ownership - Who Owns

1 week from now

Who owns Neuphoria Therapeutics? Neuphoria Therapeutics (NASDAQ: NEUP) is owned by 0.85% institutional shareholders, 2.26% Neuphoria Therapeutics insiders, and 96.88% retail …

wallstreetzen.com

42%
OFF

Who Owns Iterum Therapeutics? - WallStreetZen

1 week from now

Who owns Iterum Therapeutics? Iterum Therapeutics ( NASDAQ : ITRM ) is owned by 7.42% institutional shareholders, 82.82% Iterum Therapeutics insiders, and 9.76% retail investors. Ra …

wallstreetzen.com

93%
OFF

Arcturus Therapeutics Holdings Inc Stock Ownership - WallStreetZen

1 week from now

Arcturus Therapeutics Holdings (NASDAQ: ARCT) is owned by 96.93% institutional shareholders, 13.61% Arcturus Therapeutics Holdings insiders, and 0.00% retail investors. Joseph E. Payne …

wallstreetzen.com

02%
OFF

Who Owns Autolus Therapeutics? - WallStreetZen

1 week from now

Who owns Autolus Therapeutics? Autolus Therapeutics ( NASDAQ : AUTL ) is owned by 67.02% institutional shareholders, 0.00% Autolus Therapeutics insiders, and 32.98% retail investors. …

wallstreetzen.com

54%
OFF

Who Owns Fulcrum Therapeutics? - WallStreetZen

1 week from now

Who owns Fulcrum Therapeutics? Fulcrum Therapeutics ( NASDAQ : FULC ) is owned by 101.54% institutional shareholders, 61.37% Fulcrum Therapeutics insiders, and 0.00% retail …

wallstreetzen.com

FAQs about Who owns Regulus Therapeutics? - WallStreetZen Coupon?

Who owns Regulus Therapeutics?

Our data indicates that hedge funds own 6.5% of Regulus Therapeutics. That catches my attention because hedge funds sometimes try to influence management, or bring about changes that will create near term value for shareholders. Our data shows that Federated Hermes, Inc. is the largest shareholder with 20% of shares outstanding. ...

Should institutional investors invest in Regulus Therapeutics?

As you can see, institutional investors have a fair amount of stake in Regulus Therapeutics. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. ...

Do hedge funds own Regulus Therapeutics?

Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. Our data indicates that hedge funds own 6.5% of Regulus Therapeutics. ...

Why did Regulus join GlaxoSmithKline?

In April 2008, Regulus and GlaxoSmithKline (GSK) entered into a microRNA-focused strategic alliance for the discovery, development and commercialization of novel microRNA-targeted therapeutics to treat inflammatory diseases such as rheumatoid arthritis. ...